- Policy
- July 16, 2018
- 208 views
DCGI canceled the license for Diclofenac injection marketed by Novartis
With the raised concern by the Indian health ministry panel the license of Diclofenac injection sold by Novartis has been canceled by DCGI. The brand name of the Diclofenac painkiller…
You Missed
NCB seizes Rs 9.2 crore assets of ‘prime accused’ in transnational drugs trafficking case from Noida

NCB seizes Rs 9.2 crore assets of ‘prime accused’ in transnational drugs trafficking case from Noida
